A0A6D2XS62 (A0A6D2XS62_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)

Cyclin K UniProtKBInterProInteractive Modelling

580 aa; Sequence (Fasta) ; 5 identical sequences: Homo sapiens: O75909; Theropithecus gelada: A0A8D2JWZ1; Papio anubis: A0A096NJP9; Macaca mulatta: F7DAF2; Cercocebus atys: A0A2K5N2N4

Available Structures

41 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of the Human Cdk12-Cyclink Complex Heteromer
O75909; Q9NYV4;
20-267
1005I1;
Structure of DDB1 bound to DS17-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100GOL;RQL;
Structure of DDB1 bound to DS16-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
10010×SO4;RNF;
Structure of DDB1 bound to DS22-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RQL;
Structure of DDB1 bound to DS18-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
10012×SO4;RVQ;
Structure of DDB1 bound to SR-4835-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RMF;CIT;
Structure of DDB1 bound to 919278-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100CIT;RVH;
Structure of DDB1 bound to DS43-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100CIT;RQ9;
Structure of DDB1 bound to Z7-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
10010×SO4;RP9;
Structure of DDB1 bound to 21195-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100EDO;RS5; 10×SO4;
Structure of DDB1 bound to DS61-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RQ5;
Structure of DDB1 bound to Z11-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
10012×SO4;RVU;
Structure of DDB1 bound to DS59-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RMX;
Structure of DDB1 bound to DS15-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
10011×SO4;T6X;
Structure of DDB1 bound to DS11-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100EDO;SO4;RSU;
Structure of DDB1 bound to DS30-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
10011×SO4;RWN;
Structure of DDB1 bound to DS08-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RWE;
Structure of DDB1 bound to dCeMM4-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100CIT;RNU;
Structure of DDB1 bound to DS19-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100EDO;SO4;RSI;
Structure of DDB1 bound to DS55-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RQE;
Structure of DDB1 bound to CR8-engaged CDK12-cyclinK Heteromer
O75909; Q16531; Q9NYV4;
20-267
100RC8;
Structure of DDB1 bound to DRF-053-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100EDO;SO4;RV6;
Structure of DDB1 bound to roscovitine-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RRC;
Structure of DDB1 bound to HQ461-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100CIT;RPW;
Structure of DDB1 bound to DS24-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RLC;
Structure of DDB1 bound to DS06-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RUW;
Structure of DDB1 bound to DS50-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RQU;
Structure of DDB1 bound to WX3-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RR9;
Structure of DDB1 bound to dCeMM3-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-267
100SO4;RKO;
Structure of DDB1/Cdk12/Cyclin K with molecular glue SR-4835 Heteromer
O75909; Q16531; Q9NYV4;
20-267
100RMF;
Structure of DDB1 bound to Z12-engaged CDK12-cyclin K Heteromer
O75909; Q16531; Q9NYV4;
20-266
10012×SO4;RW6;
Crystal structure of human Cdk12/Cyclin K in complex with ADP-aluminum fluoride Heteromer
O75909; Q9NYV4;
20-265
100ADP;AF3;MG;EDO;
Crystal structure of human Cdk12/Cyclin K in complex with the inhibitor BSJ-01-175 Heteromer
O75909; Q9NYV4;
20-265
100UUB;
Crystal structure of human Cdk13/Cyclin K in complex with the inhibitor THZ531 Heteromer
O75909; Q14004;
21-264
1005I1;
Crystal structure of human Cdk13/Cyclin K in complex with ADP-aluminum fluoride Heteromer
O75909; Q14004;
21-262
100ADP;AF3;MG;
Crystal structure of the human CDK12-cyclin K complex bound to AMPPNP Heteromer
O75909; Q9NYV4;
22-262
100
Crystal structure of human CDK12/CyclinK in complex with an inhibitor Heteromer
O75909; Q9NYV4;
20-259
100MG;CJM;EDO;
Crystal structure of human Cdk12/Cyclin K in complex with inhibitor SR-4835 Heteromer
O75909; Q9NYV4;
22-260
100RMF;
Crystal structure of the human CDK12-cyclinK complex Heteromer
O75909; Q9NYV4;
22-260
100
Structure of CDK12/CycK in complex with a small molecule inhibitor N-(4-(1-methyl-1H-pyrazol-4-yl)p… Heteromer
O75909; Q9NYV4;
22-259
100MG;8M1;
Crystal structure of Cyclin Kmonomer14-267
100ACT;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
9fmr.1.Fmonomer0.5620-262
100.00